It is estimated that 85% of the disease-causing mutations occur in the exome., even exome (protein-coding regions) composes a very small fraction (~1%) of the genome. For this reason, exome sequencing provides a cost-effective alternative to whole genome sequencing. In this webinar, we will go over hWES project workflow, bioinformatics analysis options for your data, as well as Novogene powered case study, which will help you discover how our services can empower your research benefits. Whether you are conducting studies in rare mendelian disorders, complex disease, cancer research, or human population studies, Novogene’s comprehensive human whole exome sequencing (hWES) service provides a high-quality, affordable, and convenient solution.